Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11426393 Prolyl hydroxylase inhibitors and methods of use

Patent 11426393 was granted and assigned to Akebia Therapeutics on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11883386 Prolyl hydroxylase inhibitors and methods of use
0
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Angelique Sun Boyer0
Artem G. Evdokimov0
Kenneth D. Greis0
Namal C. Warshakoon0
Richard Masaru Kawamoto0
Shengde Wu0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Akebia Therapeutics
Akebia Therapeutics
0
Current Assignee
Akebia Therapeutics
Akebia Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114263930
Date of Patent
August 30, 2022
0
Patent Application Number
169080920
Date Filed
June 22, 2020
0
Patent Citations
‌
US Patent 10149842 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
0
‌
US Patent 10150734 Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
0
‌
US Patent 10246416 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
0
‌
US Patent 10596158 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
0
‌
US Patent 10729681 Prolyl hydroxylase inhibitors and methods of use
0
‌
US Patent 10738010 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
0
‌
US Patent 11065237 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
0
‌
US Patent 11267785 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
0
Patent Primary Examiner
‌
Daniel R Carcanague
0
CPC Code
‌
C07D 213/81
0
‌
C07D 213/65
0
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 31 Aug, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 31 Aug, 2022
Edits made to:
Infobox (+19 properties)
Article (+304 characters)
‌

 US Patent 11426393 Prolyl hydroxylase inhibitors and methods of use

Article

The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Infobox
Is a
Patent
Patent
Patent Applicant
Akebia Therapeutics
Akebia Therapeutics
Current Assignee
Akebia Therapeutics
Akebia Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11426393
Date of Patent
August 30, 2022
Patent Application Number
16908092
Date Filed
June 22, 2020
Patent Citations
‌
US Patent 10149842 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
‌
US Patent 10150734 Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
‌
US Patent 10246416 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
‌
US Patent 10596158 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
‌
US Patent 10729681 Prolyl hydroxylase inhibitors and methods of use
‌
US Patent 10738010 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
‌
US Patent 11065237 Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
‌
US Patent 11267785 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
Patent Primary Examiner
‌
Daniel R Carcanague
CPC Code
‌
C07D 213/81
‌
C07D 213/65

Find more entities like US Patent 11426393 Prolyl hydroxylase inhibitors and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo